Continuous TQL Block for Elective Cesarean Section

• Status: Completed
• Trial end date: 2020-04-08
• Target enrollment: 0
• Participant gender: Female

Summary

The aim of this study is to investigate whether it is possible to prolong time to first opioid with the TQL block by inserting catheters bilaterally, providing continuous analgesia, in patients undergoing elective CS. Our hypothesis is that it will be possible to significantly extend time to first opioid with the blockade by 66.6%, increasing it from a mean of 5.6 hours to a mean of 10 hours.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zealand University Hospital
• Treatments: Ropivacaine

Criteria

Inclusion Criteria:

• 18+ years of age.

• Scheduled for elective Caesarean Section in spinal anaesthesia.

• Have received thorough information, verbally and in written, and signed the "Informed Consent" form on participation in the trial.

Exclusion Criteria:

• Inability to cooperate

• Inability to understand Danish

• Allergy to local anaesthetics or opioids

• Excessive daily intake of opioids, according to the discretion of the investigator

• Local infection at the site of injection or systemic infection

• Difficult visualisation of muscular and fascial structures on ultrasound, necessary to correct blockade and catheter placement.